SCHEMBL7007538

SCHEMBL7007538

N#Cc1[c]cccc1-c1ccc(Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
PTGES O14684 1/20 0.37
ALDH1A1 P00352 4/20 0.34
MAPK1 P28482 2/20 0.34
ERBB2 P04626 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
TSHR P16473 3/20 0.33
KDM4E B2RXH2 3/20 0.33
LMNA P02545 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PPARG P37231 2/20 0.33
NCOA2 Q15596 2/20 0.33
NCOA1 Q15788 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5664674 0.83 L3MBTL1 (0.39) NPSR1KMT2AMEN1ALDH1A1MAPK1
SCHEMBL8065385 0.78 KIF11 (0.47) SMN1; SMN2TSHRKDM4ELMNATP53
SCHEMBL7026479 0.76 ALDH1A1 (0.38) ALDH1A1MAPK1SMN1; SMN2TSHRLMNA
SCHEMBL9869167 0.76 PTGS2 (0.51)
SCHEMBL1431628 0.75 ALDH1A1 (0.41) NPSR1KMT2AMEN1ALDH1A1MAPK1
SCHEMBL6192365 0.74 KDM4E (0.33) NPSR1KDM4EHPGD
SCHEMBL9667400 0.73 MAPK1 (0.39) NPSR1KMT2AMEN1ALDH1A1MAPK1
SCHEMBL4673934 0.73 ALDH1A1 (0.39) NPSR1KMT2AMEN1ALDH1A1MAPK1
SCHEMBL979388 0.72
SCHEMBL21647122 0.72 ALDH1A1 (0.38) NPSR1KMT2AMEN1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343768-A1 ARYL AND AMINOARYL SUBSTITUTED SEROTONIN RECEPTOR AGONIST AND ANTAGONIST LIGANDS Bristol-Myers Squibb Pharma Company (US) 2003-09-17 EP claimed
JP-2003502336-A 2003-01-21 JP claimed
WO-2002059082-A2 ARYL AND AMINOARYL SUBSTITUTED SEROTONIN RECEPTOR AGONIST AND ANTAGONIST LIGANDS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-08-01 WO claimed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP claimed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO claimed
EP-1345942-A2 PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS Bristol-Myers Squibb Pharma Company (US) 2003-09-24 EP disclosed
WO-2002059127-A2 PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-08-01 WO disclosed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP disclosed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO disclosed